Please login to the form below

Not currently logged in
Email:
Password:

DAVID

This page shows the latest DAVID news and features for those working in and with pharma, biotech and healthcare.

FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

We have come a long way in understanding the role of dual immunotherapy-based approaches in cancer and the potential impact on patients’ long-term outcomes,” said David Carbone, CheckMate -9LA

Latest news

More from news
Approximately 6 fully matching, plus 767 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 66 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 141 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 83 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics